This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitá Degli Studi Di Padova. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Mario Angelo Primo Pagano
Introduction
Mario Angelo Primo Pagano is an accomplished inventor based in Padua, Italy. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential therapeutic applications. His work focuses on innovative solutions for treating various types of cancer.
Latest Patents
Mario holds a patent for a 1-phenylpropanone compound, which is described as having the formula (I). This compound features X as CH or an atom selected from the group consisting of O, S, and Se, with n being an integer from 4 to 6. The substituent A can be selected from a variety of groups, including 4-morpholyl and 1-piperidinyl, and may be optionally substituted with a (C-C)alkyl or (C-C)acyl substituent. Notably, when X is CH, n is equal to 5. This invention is aimed at serving as an antitumoral agent in the treatment of breast cancer, chronic lymphatic leukemia, or neuroblastoma. The patent highlights the potential of these new compounds as effective antitumoral agents.
Career Highlights
Mario is affiliated with the Università Degli Studi Di Padova, where he engages in research and development activities. His academic background and expertise in chemistry have positioned him as a key figure in his field. His innovative work has garnered attention for its potential impact on cancer treatment.
Collaborations
Mario collaborates with esteemed colleagues, including Elena Tibaldi and Anna Maria Brunati. Their combined efforts contribute to advancing research in the field of antitumoral agents.
Conclusion
Mario Angelo Primo Pagano is a notable inventor whose work in developing 1-phenylpropanone compounds showcases his commitment to addressing critical health challenges. His contributions to cancer treatment through innovative compounds highlight the importance of research and collaboration in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
